Literature DB >> 20609349

Testimony from the bedside: from Coley's toxins to targeted immunotherapy.

Jin Mo Park1, David E Fisher.   

Abstract

A new clinical study reported in the New England Journal of Medicine unveils the long-awaited outcome of anti-CTLA-4 therapy for melanoma. It provides grounds for continued enthusiasm for cancer immunotherapy, deepens our thoughts on underlying mechanisms, and suggests exciting next steps. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID： 20609349     DOI： 10.1016/j.ccr.2010.06.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  8 in total

1.  Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.

Authors:  Karen M Kaluza; Timothy Kottke; Rosa Maria Diaz; Diana Rommelfanger; Jill Thompson; Richard Vile
Journal:  Hum Gene Ther       Date:  2012-08-13       Impact factor: 5.695

2.  N-dihydrogalactochitosan as a potent immune activator for dendritic cells.

Authors:  Ahmed El-Hussein; Samuel S K Lam; Joseph Raker; Wei R Chen; Michael R Hamblin
Journal:  J Biomed Mater Res A       Date:  2017-01-10       Impact factor: 4.396

Review 3.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 4.  The chemical biology of IL-12 production via the non-canonical NFkB pathway.

Authors:  Peter D Koch; Mikael J Pittet; Ralph Weissleder
Journal:  RSC Chem Biol       Date:  2020-07-22

Review 5.  Harnessing the Microbiome to Enhance Cancer Immunotherapy.

Authors:  Michelle H Nelson; Marshall A Diven; Logan W Huff; Chrystal M Paulos
Journal:  J Immunol Res       Date:  2015-05-25       Impact factor: 4.818

Review 6.  Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System.

Authors:  Tobias Achu Muluh; Zhuo Chen; Yi Li; Kang Xiong; Jing Jin; ShaoZhi Fu; JingBo Wu
Journal:  Int J Nanomedicine       Date:  2021-03-25

7.  Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin.

Authors:  C Maletzki; U Klier; W Obst; B Kreikemeyer; M Linnebacher
Journal:  Clin Dev Immunol       Date:  2012-11-11

8.  Regulatory T Cells Beyond Autoimmunity: From Pregnancy to Cancer and Cardiovascular Disease.

Authors:  Elisa Martini; Silvia Giugliano; Maria Rescigno; Marinos Kallikourdis
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.